These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18174672)

  • 1. Progress in pathogenesis and therapy of vasculitis syndrome.
    Origuchi T; Ichinose K; Tamai M; Nakamura H; Kawakami A; Eguchi K
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):432-43. PubMed ID: 18174672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatments of ANCA-associated vasculitis.
    Kallenberg CG; Tervaert JW
    Sarcoidosis Vasc Diffuse Lung Dis; 2000 Jun; 17(2):125-9. PubMed ID: 10957760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA-associated small-vessel vasculitis.
    Mansi IA; Opran A; Rosner F
    Am Fam Physician; 2002 Apr; 65(8):1615-20. PubMed ID: 11989638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
    de Groot K; Harper L; Jayne DR; Flores Suarez LF; Gregorini G; Gross WL; Luqmani R; Pusey CD; Rasmussen N; Sinico RA; Tesar V; Vanhille P; Westman K; Savage CO;
    Ann Intern Med; 2009 May; 150(10):670-80. PubMed ID: 19451574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis.
    Haubitz M; Schulzeck P; Schellong S; Schulze M; Koch KM; Brunkhorst R
    Arthritis Rheum; 1997 Sep; 40(9):1680-4. PubMed ID: 9324023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?
    Nachman PH
    Nat Rev Nephrol; 2009 May; 5(5):254-6. PubMed ID: 19384325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Kallenberg CG; Rarok A; Stegeman CA; Limburg PC
    Autoimmun Rev; 2002 Feb; 1(1-2):61-6. PubMed ID: 12849060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
    Feldmann M; Pusey CD
    J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-endothelial cell antibodies(AECA) are associated with disease activity of propylthiouracil induced antineutrophil cytoplasmic antibody (ANCA) positive vasculitis].
    Yu F; Zhao MH; Zhang Y; Zhang YK
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):374-7. PubMed ID: 16086055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
    Holle JU; Gross WL
    J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects in ANCA-associated vasculitides].
    Lamprecht P
    Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclophosphamide versus bolus in Wegener's granulomatosis and other ANCA-related vasculitides: advantages and disadvantages].
    Reinhold-Keller E; Warnatz K
    Z Rheumatol; 2009 Jun; 68(4):345-8. PubMed ID: 19093127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
    Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
    J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.